As China's new drug R&D enters the 'deep waters' of homogeneous competition, the path for followers has become increasingly ...

Explore AI in drug discovery and its journey from promise to proof in 2025 with significant achievements and challenges faced.

In the pursuit of solutions to complex global challenges including disease, energy demands, and climate change, scientific ...

For decades, Nigeria’s response to illicit drug cultivation has been largely enforcement driven, centred on arrests, seizures ...

On Dec 19, 2025, the US Food and Drug Administration (FDA) announced a major milestone by qualifying total hip bone mineral density (BMD), assessed by dual-energy X-ray absorptiometry, as a surrogate ...

A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...

Over the past four decades, rare disease drug development has evolved from a scientific aspiration into a central pillar of biopharmaceutical innovation. Regulatory reforms, scientific breakthroughs, ...

For much of the past decade, India’s role in global pharmaceutical outsourcing was defined narrowly, efficient execution, strong chemistry and cost advantage. That narrative is now being rewritten.

Automation and AI are revolutionizing the pharmaceutical industry, optimizing technical development and enabling faster, more ...

Regulatory challenges have been even more top of mind than usual given recent upheaval at the FDA. BioSpace spoke to three industry experts about key issues, which include applying new artificial ...

Korean Biosimilar Firms Capitalize on Global Patent Expirations Samsung Bioepis, Celltrion Target Keytruda, Dupixent ...

Overview AI is speeding up drug discovery by analyzing large biological and chemical data in a short time.Deep learning and AI systems help design new drug mole ...